Nektar Therapeutics (NKTR)
NASDAQ: NKTR · IEX Real-Time Price · USD
1.380
-0.040 (-2.82%)
At close: Apr 24, 2024, 4:00 PM
1.410
+0.030 (2.17%)
After-hours: Apr 24, 2024, 5:04 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $253.39 million as of April 24, 2024. Its market cap has increased by 36.23% in one year.
Market Cap
253.39M
Enterprise Value
70.31M
1-Year Change
36.23%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $253.39M, a decrease of -47.06%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 260.70M | 4.41% |
| Apr 22, 2024 | 249.70M | 9.66% |
| Apr 19, 2024 | 227.70M | -6.06% |
| Apr 18, 2024 | 242.40M | -2.22% |
| Apr 17, 2024 | 247.90M | -9.39% |
| Apr 16, 2024 | 273.60M | -5.10% |
| Apr 15, 2024 | 288.30M | -5.97% |
| Apr 12, 2024 | 306.60M | 5.69% |
| Apr 11, 2024 | 290.10M | 22.46% |
| Apr 10, 2024 | 236.90M | 3.22% |
| Apr 9, 2024 | 229.50M | -4.57% |
| Apr 8, 2024 | 240.50M | -0.78% |
| Apr 5, 2024 | 242.40M | - |
| Apr 4, 2024 | 242.40M | 26.91% |
| Apr 3, 2024 | 191.00M | 9.52% |
| Apr 2, 2024 | 174.40M | 5.06% |
| Apr 1, 2024 | 166.00M | -3.21% |
| Mar 28, 2024 | 171.50M | 5.54% |
| Mar 27, 2024 | 162.50M | -1.69% |
| Mar 26, 2024 | 165.30M | 1.35% |
| Mar 25, 2024 | 163.10M | -2.68% |
| Mar 22, 2024 | 167.60M | 1.76% |
| Mar 21, 2024 | 164.70M | -0.36% |
| Mar 20, 2024 | 165.30M | 3.70% |
| Mar 19, 2024 | 159.40M | 2.11% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 23andMe Holding Co. | 233.20M |
| Boundless Bio | 232.85M |
| 2seventy bio | 231.93M |
| Conduit Pharmaceuticals | 230.35M |
| Ovid Therapeutics | 228.39M |
| Aldeyra Therapeutics | 227.34M |
| Inovio Pharmaceuticals | 226.23M |
| Foghorn Therapeutics | 225.60M |